Eisenberg Brothers will Distribute and Support Partek Software
News Jun 02, 2006
Partek Incorporated and Eisenberg Brothers Ltd have announced a distribution agreement under which Eisenberg Brothers will provide sales and marketing in Israel for each of Partek’s statistical analysis and data visualization software solutions.
The software solutions include Partek™ Genomics Suite for microarray data, Partek™ Discovery Suite for multi-dimensional non-microarray data, Partek™ QSAR Solution for chemistry data, and Partek™ Screener’s Solution for HTS screening data.
Partek Genomics Suite is Affymetrix GeneChip-compatible™ for gene expression, exon expression, and chromosomal copy number analysis.
"Eisenberg Brothers has a strong history in providing high end solutions to research organizations and businesses," said Tom Downey, president of Partek Inc.
"This exciting partnership will provide the scientific communities in Israel with powerful statistical software backed by outstanding support."
"We are happy to add Partek to our portfolio of world leading suppliers," said Amos Grundwag, Genomics and Bioinformatics manager at Eisenberg Brothers. Ltd.
"We recognize partek to be the best overall software solution for a wide range of biological and statistical challenges that the scientific community is currently handling."
"Partek also has some wonderful visualization tools which make it a winner."
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018